UACA Antikörper
Kurzübersicht für UACA Antikörper (ABIN6296769)
Target
Alle UACA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse anti-Human/Mouse UACA Antibody [Sodium Azide Free]
-
Spezifität
- Nuclear membrane
-
Aufreinigung
- Nuclei of myeloid leukemia biopsy cells were used as the immunogen for the UACA antibody.
-
Immunogen
- Nuclei of myeloid leukemia biopsy cells were used as the immunogen for the UACA antibody.
-
-
-
-
Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Western blot: 0.5-1 μg/mL -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- UACA (Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA))
-
Andere Bezeichnung
- Uveal autoantigen with coiled-coil domains and ankyrin repeats
-
Hintergrund
-
Target Description: UACA (Uveal Autoantigen with Coiled-coil domains and Ankyrin repeats) is a 1,416 amino acid nuclear membrane protein. It was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves' disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
Gene Symbol: UACA///KIAA1561
-
Gen-ID
- 55075
-
UniProt
- Q9BZF9
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-